Ask the Experts

Video Series

Management of Cytokine Release Syndrome and Neurotoxicity for Patients Receiving Bispecific Antibodies for the Treatment of Multiple Myeloma

This video provides guidance on managing cytokine release syndrome (CRS) and neurotoxicity in multiple myeloma patients receiving bispecific antibodies. The conversation covers the identification and grading of these toxicities, step-up dosing and mitigation strategies, operational REMS requirements, and essential practices for patient education and emergency response.

About the Speakers

Donna D. Catamero

ANP-BC, OCN, CCRC

Donna Catamero received a Bachelor of Science in nursing from Simmons College in 2002 and her Master of Science in nursing from NYU in 2010. She is currently enrolled in the Doctor of Nursing Practice program at Quinnipiac University. For 20 years, Ms. Catamero has been involved in clinical research. She worked as a Nurse Practitioner in the Multiple Myeloma Program at New York University Langone Medical Center in New York City and later at Mount Sinai, also in New York City. Ms. Catamero has been a member of the International Myeloma Foundation (IMF) Nurse Leadership Board (NLB) since 2014. She has served as a chairperson for roundtables and advisory boards and presented at the IMF Patient & Family Seminars.

Samantha Shenoy

MS, MSN, ACNP-BC

Samantha Shenoy, MS, MSN, ACNP-BC is a Board-Certified Nurse Practitioner specializing in multiple myeloma and plasma cell dyscrasias at the University of California, San Francisco (UCSF) Medical Center. She earned her Masters of Science in Nursing from UCSF School of Nursing. For nearly two decades she has managed patients throughout their treatment trajectory, with a clinical focus on the mitigation, monitoring, and management of toxicities associated with CAR T-cell therapy, Bispecific Antibody Therapy and other approved and experimental multiple myeloma treatments. Ms. Shenoy an active member of the International Myeloma (IMF) Nurse Leadership Board (NLB), the Oncology Nursing Society and the International Myeloma Society.

Tiffany Richards

PhD, ANP, AOCNP

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Sponsored by Johnson & Johnson